Sonomind
PrivateLast Round
Series A
May 13, 2026
Total Funding Raised
$27.03M
Company Overview
Sonomind is a medical device company that develops non-invasive, personalized neuromodulation technology using low-intensity focused ultrasound to treat depression and other neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, 3D Printing, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonomind Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Sonomind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2026 | ||||
| Seed | Sep 24, 2025 |
Sonomind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Critical Path Ventures | Seed, Series A |
| Bpifrance | Seed, Series A |
Sonomind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sonomind's valuation, stock price, and market status.